Article
Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro
10 Sept 2021
Abstract excerpt
Abstract Effective vaccines are slowing the COVID-19 pandemic, but SARS-CoV-2 will likely remain an issue in the future making it important to have therapeutics to treat patients. There are few options for treating patients with COVID-19. We show probenecid potently blocks SARS-CoV-2 replication in mammalian cells and virus replication in a hamster model. Furthermore, we demonstrate that plasma concentrations up...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
